Clare L. Scott
Impact in
- Oncology top 0.1%
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
- Reproductive Medicine top 0.2%
- Ovarian cancer diagnosis and treatment
Papers in
- Oncology 75
- PARP inhibition in cancer therapy 48
- Cancer-related Molecular Pathways 8
-
- Cell death mechanisms and regulation 11
- DNA Repair Mechanisms 8
- Co-authors
- Michael Friedländer (25 shared papers)Ursula A. Matulonis (17 shared papers)Andreas Strasser (24 shared papers)James Carmichael (2 shared papers)Jonathan A. Ledermann (19 shared papers)Charlie Gourley (16 shared papers)Philipp Harter (13 shared papers)Tamar Safra (12 shared papers)
- Journals
- Journal of Clinical Oncology (25 papers)Blood (12 papers)Annals of Oncology (6 papers)Cancer Research (5 papers)Therapeutic Advances in Medical Oncology (5 papers)
- Partner nations
- AustraliaUnited KingdomUnited States
In The Last Decade
Clare L. Scott
167 papers receiving 12.4k citations
Clare L. Scott's Hit Papers
Peers
Comparison fields: 5 of 158
- Oncology 6.3k
- Reproductive Medicine 1.9k
- Cancer Research 1.3k
- Immunology 1.7k
- Molecular Biology 5.4k
Countries citing papers authored by Clare L. Scott
This map shows the geographic impact of Clare L. Scott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clare L. Scott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clare L. Scott more than expected).
Fields of papers citing papers by Clare L. Scott
This network shows the impact of papers produced by Clare L. Scott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clare L. Scott. The network helps show where Clare L. Scott may publish in the future.
Co-authors
The 25 scholars most cited alongside Clare L. Scott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 175 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial Hit paper breakdown → | 2010 | 1818 |
| 2 | Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer Hit paper breakdown → | 2012 | 1413 |
| 3 | Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial Hit paper breakdown → | 2014 | 1102 |
| 4 | The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized Hit paper breakdown → | 2006 | 1043 |
| 5 | SOCS1 Is a Critical Inhibitor of Interferon γ Signaling and Prevents the Potentially Fatal Neonatal Actions of this Cytokine Hit paper breakdown → | 1999 | 661 |
| 6 | 2016 | 324 | |
| 7 | 2020 | 285 | |
| 8 | 2015 | 271 | |
| 9 | 2011 | 247 | |
| 10 | 2013 | 229 | |
| 11 | 2012 | 222 | |
| 12 | 2007 | 170 | |
| 13 | 2008 | 161 | |
| 14 | 2009 | 142 | |
| 15 | 2007 | 141 | |
| 16 | 1997 | 131 | |
| 17 | 2009 | 130 | |
| 18 | 2011 | 128 | |
| 19 | 2003 | 128 | |
| 20 | 2020 | 122 |
About Clare L. Scott
Clare L. Scott is a scholar working on Oncology, Molecular Biology, Reproductive Medicine, Genetics and Cancer Research, having authored 175 papers that have together received 12.8k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (48 papers), Ovarian cancer diagnosis and treatment (33 papers), BRCA gene mutations in cancer (23 papers), Cancer Genomics and Diagnostics (16 papers), Cell death mechanisms and regulation (11 papers), DNA Repair Mechanisms (8 papers), Cancer-related Molecular Pathways (8 papers) and Endometrial and Cervical Cancer Treatments (8 papers). The work is most often cited by research in Oncology (6.3k citations), Reproductive Medicine (1.9k citations), Cancer Research (1.3k citations), Immunology (1.7k citations) and Molecular Biology (5.4k citations). Clare L. Scott has collaborated with scholars based in Australia, United Kingdom and United States. Frequent co-authors include Michael Friedländer, Ursula A. Matulonis, Andreas Strasser, James Carmichael, Jonathan A. Ledermann, Charlie Gourley, Philipp Harter, Tamar Safra, Ignace Vergote and Ronnie Shapira‐Frommer. Their work appears in journals such as Journal of Clinical Oncology, Blood, Annals of Oncology, Cancer Research and Therapeutic Advances in Medical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.